Active, Not Recruiting
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
NCT03097939
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- National Cancer Center Singapore Singapore